IDEAYA Biosciences, Inc.
IDYA· Nasdaq
IDYAIDEAYA Biosciences, Inc.
Filed Nov 12, 2020 · 10-Q · 43 days after period end · 0001564590-20-053546
| Metric | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|
| Revenue | $8.97M | — | — |
| Net Income | -$4.93M | -$10.97M | -$13.05M |
| EPS Diluted | -$0.17 | -$0.54 | -$13.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IDEAYA Biosciences, Inc. · CIK 1676725 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end
